All lobbying filings
GOODRX, INC.
GOODRX, INC. filed a Q3 report for GOODRX, INC. on October 20, 2025.
Lobbying for GOODRX, INC.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$310,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
2
Lobbying activity
2
Monitoring federal legislation and outreach to congressional offices.
-Issues regarding prescription drug pricing. -Issues regarding telehealth.